Daewon Pharmaceutical Co. Ltd. (003220) - Cash Flow Conversion Efficiency

Latest as of June 2026: -0.016x

Based on the latest financial reports, Daewon Pharmaceutical Co. Ltd. (003220) has a cash flow conversion efficiency ratio of -0.016x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-4.39 Billion ≈ $-2.97 Million USD) by net assets (₩275.73 Billion ≈ $186.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 003220 market cap overview for the company's overall valuation and market capitalisation.

Daewon Pharmaceutical Co. Ltd. - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Daewon Pharmaceutical Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Daewon Pharmaceutical Co. Ltd. for real-time trading data and today's change.

Daewon Pharmaceutical Co. Ltd. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Daewon Pharmaceutical Co. Ltd. ranked by their cash flow conversion efficiency. Review free cash flow generation of Daewon Pharmaceutical Co. Ltd. to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Beammwave AB B ST:BEAMMW-B	-0.035x
Lastminute.com NV F:09B	-0.327x
Sona Topas Tourism Industry JK:SONA	0.066x
OPPSTAR KLSE:0275	0.029x
SKY Metals Ltd AU:SKY	-0.040x
Smith-Midland Corp NASDAQ:SMID	-0.009x
Apollo Silver Corp V:APGO	-0.027x
D&D Platform Reit Co Ltd KO:377190	N/A

Annual Cash Flow Conversion Efficiency for Daewon Pharmaceutical Co. Ltd. (2011–2025)

The table below shows the annual cash flow conversion efficiency of Daewon Pharmaceutical Co. Ltd. from 2011 to 2025. Also see 003220 asset base for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩274.58 Billion ≈ $186.08 Million	₩42.31 Billion ≈ $28.68 Million	0.154x	+46.01%
2024-12-31	₩284.58 Billion ≈ $192.85 Million	₩30.04 Billion ≈ $20.35 Million	0.106x	-46.09%
2023-12-31	₩264.26 Billion ≈ $179.09 Million	₩51.73 Billion ≈ $35.06 Million	0.196x	+46.13%
2022-12-31	₩248.77 Billion ≈ $168.58 Million	₩33.33 Billion ≈ $22.58 Million	0.134x	+30.54%
2021-12-31	₩218.40 Billion ≈ $148.01 Million	₩22.41 Billion ≈ $15.19 Million	0.103x	-12.49%
2020-12-31	₩212.77 Billion ≈ $144.19 Million	₩24.95 Billion ≈ $16.91 Million	0.117x	-22.67%
2019-12-31	₩204.22 Billion ≈ $138.39 Million	₩30.97 Billion ≈ $20.99 Million	0.152x	-30.60%
2018-12-31	₩183.20 Billion ≈ $124.15 Million	₩40.03 Billion ≈ $27.13 Million	0.219x	+761.41%
2017-12-31	₩168.13 Billion ≈ $113.94 Million	₩4.27 Billion ≈ $2.89 Million	0.025x	-80.23%
2016-12-31	₩162.01 Billion ≈ $109.79 Million	₩20.79 Billion ≈ $14.09 Million	0.128x	-26.10%
2015-12-31	₩148.66 Billion ≈ $100.75 Million	₩25.82 Billion ≈ $17.50 Million	0.174x	+33.89%
2014-12-31	₩134.51 Billion ≈ $91.16 Million	₩17.45 Billion ≈ $11.82 Million	0.130x	+29.76%
2013-12-31	₩123.25 Billion ≈ $83.53 Million	₩12.32 Billion ≈ $8.35 Million	0.100x	-18.36%
2012-12-31	₩112.92 Billion ≈ $76.53 Million	₩13.83 Billion ≈ $9.37 Million	0.122x	-29.04%
2011-12-31	₩103.92 Billion ≈ $70.42 Million	₩17.93 Billion ≈ $12.15 Million	0.173x	--

About Daewon Pharmaceutical Co. Ltd.

KO:003220 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$118.96 Million

₩175.54 Billion KRW

Market Cap Rank

#18564 Global

#877 in Korea

Share Price

₩8190.00

Change (1 day)

-0.73%

52-Week Range

₩7240.00 - ₩13450.00

All Time High

₩23535.34